New Developments In Diabetes Drugs for Parkinson’s

New Developments In Diabetes Drugs for Parkinson’s
At the forefront of treatments for diabetes is a class of drug called glucagon-like peptide 1 receptor (or GLP-1R) agonists. An agonist is a drug that activates a protein on a cell called a receptor, which subsequently stimulates additional activity inside that cell. We know a great deal about how these drugs work in humans - they are widely used ... read more
Source: The Cure Parkinson’s TrustPublished on 2020-01-30